Furthermore, it is important to recognise that the predicted absolute benefit of an intervention is dependent on the absolute risk and thus those with prior CVD events are more likely to experience a benefit over intermediate time frames than those with cardiovascular risk factors only
There's no single "right" answer, just what works best for your specific protocol
Hargens, who also sells the patches in addition to using them herself, says she doesnt worry about a conflict of interest
Furthermore, a benefit/risk tool has been developed on the basis of current available evidence and guidelines to support primary care clinicians in selecting individuals who are most likely to benefit from GLP-1 RA therapies, in addition to indicating clinical situations where caution is needed
Research revolves around singling certain strains of probiotics, but experts agree that when it comes to the general health of the microbiome, diversity is key
Choosing the right concentration for your protocol Not all concentrations are equally practical
